| Item Type | Name |
|
Concept
|
Birds
|
|
Concept
|
Body Mass Index
|
|
Concept
|
Extracellular Matrix
|
|
Concept
|
Age Factors
|
|
Concept
|
Disease Models, Animal
|
|
Concept
|
Precision Medicine
|
|
Concept
|
Myocardial Ischemia
|
|
Concept
|
Calcium Channel Blockers
|
|
Concept
|
Echocardiography, Doppler, Color
|
|
Concept
|
Electrocardiography, Ambulatory
|
|
Concept
|
Heart Arrest
|
|
Concept
|
Aortic Valve Insufficiency
|
|
Concept
|
Survival Rate
|
|
Concept
|
Imaging, Three-Dimensional
|
|
Concept
|
Blood Pressure
|
|
Concept
|
Chromosomes, Human, Pair 18
|
|
Concept
|
Critical Pathways
|
|
Concept
|
Echocardiography, Doppler
|
|
Concept
|
Heart Failure, Systolic
|
|
Concept
|
Incidence
|
|
Concept
|
Introns
|
|
Concept
|
Recurrence
|
|
Concept
|
Morbidity
|
|
Concept
|
Hypothermia, Induced
|
|
Concept
|
Cardiac Output, Low
|
|
Concept
|
Gadolinium
|
|
Concept
|
Sex Distribution
|
|
Concept
|
Endangered Species
|
|
Concept
|
Cats
|
|
Concept
|
Coronary Aneurysm
|
|
Concept
|
Echocardiography, Three-Dimensional
|
|
Concept
|
Myocarditis
|
|
Concept
|
Disease Progression
|
|
Concept
|
Death, Sudden, Cardiac
|
|
Concept
|
Endothelium, Vascular
|
|
Concept
|
Heart Transplantation
|
|
Concept
|
History, 21st Century
|
|
Concept
|
Angioplasty, Balloon, Coronary
|
|
Concept
|
Conservation of Natural Resources
|
|
Concept
|
Genomics
|
|
Concept
|
Administration, Oral
|
|
Concept
|
Ventricular Outflow Obstruction
|
|
Concept
|
Collagen Type I
|
|
Concept
|
Genetic Testing
|
|
Concept
|
Confidence Intervals
|
|
Concept
|
Artificial Intelligence
|
|
Concept
|
Myosin Heavy Chains
|
|
Concept
|
Chi-Square Distribution
|
|
Concept
|
Disopyramide
|
|
Concept
|
Syndrome
|
|
Concept
|
Ecology
|
|
Concept
|
Chronic Disease
|
|
Concept
|
Echocardiography, Doppler, Pulsed
|
|
Concept
|
Adrenergic beta-Antagonists
|
|
Concept
|
Demography
|
|
Concept
|
Algorithms
|
|
Concept
|
Health Status
|
|
Concept
|
Kenya
|
|
Concept
|
Heart Aneurysm
|
|
Concept
|
Bundle-Branch Block
|
|
Concept
|
Cohort Studies
|
|
Concept
|
Boston
|
|
Concept
|
Echocardiography, Stress
|
|
Concept
|
Tachycardia
|
|
Concept
|
Stroke
|
|
Concept
|
Wood
|
|
Concept
|
Mortality
|
|
Concept
|
Death, Sudden
|
|
Concept
|
Acute Disease
|
|
Concept
|
Pulmonary Artery
|
|
Concept
|
Troponin
|
|
Concept
|
Colombia
|
|
Concept
|
Sarcomeres
|
|
Concept
|
Cardiomyopathies
|
|
Concept
|
Heart Failure
|
|
Concept
|
Myocardial Infarction
|
|
Concept
|
Spironolactone
|
|
Concept
|
Heart Defects, Congenital
|
|
Concept
|
Genetic Predisposition to Disease
|
|
Concept
|
Tropical Climate
|
|
Concept
|
Biopsy
|
|
Concept
|
Coronary Angiography
|
|
Concept
|
Clinical Protocols
|
|
Concept
|
Ventricular Premature Complexes
|
|
Concept
|
Procollagen
|
|
Concept
|
Commerce
|
|
Concept
|
Contrast Media
|
|
Concept
|
Glycogen Storage Disease
|
|
Concept
|
Arrhythmias, Cardiac
|
|
Concept
|
Clinical Trials as Topic
|
|
Concept
|
Aortic Valve Stenosis
|
|
Concept
|
Diastole
|
|
Concept
|
Image Enhancement
|
|
Concept
|
Ecosystem
|
|
Concept
|
Drug Evaluation, Preclinical
|
|
Concept
|
Echocardiography, Transesophageal
|
|
Concept
|
Ventricular Fibrillation
|
|
Concept
|
Hypertrophy, Left Ventricular
|
|
Concept
|
Nitrogen
|
|
Concept
|
Echocardiography
|
|
Concept
|
Adaptation, Physiological
|
|
Concept
|
Coronary Artery Bypass
|
|
Concept
|
Hypertrophy, Right Ventricular
|
|
Concept
|
Nickel
|
|
Concept
|
Diabetes Mellitus, Type 2
|
|
Concept
|
Defibrillators, Implantable
|
|
Concept
|
Insurance Claim Review
|
|
Concept
|
Retrospective Studies
|
|
Concept
|
Growth Differentiation Factor 15
|
|
Concept
|
Iatrogenic Disease
|
|
Concept
|
Organ Size
|
|
Concept
|
Mineralocorticoid Receptor Antagonists
|
|
Concept
|
Academic Medical Centers
|
|
Concept
|
Sotalol
|
|
Concept
|
Hospital Mortality
|
|
Concept
|
Wilderness
|
|
Concept
|
Decision Support Techniques
|
|
Concept
|
Mitral Valve Insufficiency
|
|
Concept
|
Cicatrix
|
|
Concept
|
Ventricular Dysfunction, Left
|
|
Concept
|
Exercise
|
|
Concept
|
Elasticity Imaging Techniques
|
|
Concept
|
Cardiomyopathy, Hypertrophic
|
|
Concept
|
History, 20th Century
|
|
Concept
|
Bibliometrics
|
|
Concept
|
Ventricular Dysfunction
|
|
Concept
|
Longitudinal Studies
|
|
Concept
|
Heart Failure, Diastolic
|
|
Concept
|
Chest Pain
|
|
Concept
|
Endomyocardial Fibrosis
|
|
Concept
|
Fatal Outcome
|
|
Concept
|
Brachial Artery
|
|
Concept
|
Hospitals, Community
|
|
Concept
|
Cause of Death
|
|
Concept
|
alpha-Galactosidase
|
|
Concept
|
Atrial Fibrillation
|
|
Concept
|
Genetic Privacy
|
|
Concept
|
Acute Coronary Syndrome
|
|
Concept
|
Biodiversity
|
|
Concept
|
Troponin T
|
|
Concept
|
Clinical Competence
|
|
Concept
|
Takotsubo Cardiomyopathy
|
|
Concept
|
Medicare
|
|
Concept
|
Action Potentials
|
|
Concept
|
Genetic Counseling
|
|
Concept
|
Mass Screening
|
|
Concept
|
Gadolinium DTPA
|
|
Concept
|
Cardiomyopathy, Hypertrophic, Familial
|
|
Concept
|
Prevalence
|
|
Concept
|
Case-Control Studies
|
|
Concept
|
Electrophysiologic Techniques, Cardiac
|
|
Concept
|
Microfilament Proteins
|
|
Concept
|
Health Status Disparities
|
|
Concept
|
Darkness
|
|
Concept
|
Diseases in Twins
|
|
Concept
|
Prospective Studies
|
|
Concept
|
Fabry Disease
|
|
Concept
|
Cross-Sectional Studies
|
|
Concept
|
Image Processing, Computer-Assisted
|
|
Concept
|
Randomized Controlled Trials as Topic
|
|
Concept
|
Evidence-Based Medicine
|
|
Concept
|
Cost of Illness
|
|
Concept
|
Arrhythmogenic Right Ventricular Dysplasia
|
|
Concept
|
Cardiotonic Agents
|
|
Concept
|
Proteomics
|
|
Concept
|
Shock, Cardiogenic
|
|
Concept
|
Elephants
|
|
Concept
|
Israel
|
|
Concept
|
Cardiovascular Abnormalities
|
|
Concept
|
Heart Valve Diseases
|
|
Concept
|
Exercise Test
|
|
Concept
|
Exercise Tolerance
|
|
Concept
|
Fires
|
|
Concept
|
Cardiomyopathy, Dilated
|
|
Concept
|
Tachycardia, Ventricular
|
|
Concept
|
Glycogen Storage Disease Type IIb
|
|
Concept
|
Cardiac Myosins
|
|
Concept
|
Risk Factors
|
|
Concept
|
Benzylamines
|
|
Concept
|
Base Sequence
|
|
Concept
|
Follow-Up Studies
|
|
Concept
|
Heart Diseases
|
|
Concept
|
Receptors, Adrenergic, alpha-2
|
|
Concept
|
Comorbidity
|
|
Concept
|
Frameshift Mutation
|
|
Concept
|
Molecular Sequence Data
|
|
Concept
|
Electrocardiography
|
|
Concept
|
Diagnostic Errors
|
|
Concept
|
Age Distribution
|
|
Concept
|
Troponin I
|
|
Academic Article
|
Advanced heart failure with preserved systolic function in nonobstructive hypertrophic cardiomyopathy: under-recognized subset of candidates for heart transplant.
|
|
Academic Article
|
Impact of Advanced Therapies for Improving Survival to Heart Transplant in Patients with Hypertrophic Cardiomyopathy.
|
|
Concept
|
Patient Reported Outcome Measures
|
|
Concept
|
Coral Reefs
|
|
Concept
|
Aquatic Organisms
|
|
Concept
|
Single-Cell Analysis
|
|
Concept
|
Renewable Energy
|
|
Concept
|
Transcriptome
|
|
Concept
|
Asymptomatic Diseases
|
|
Concept
|
Mitral Valve Annuloplasty
|
|
Concept
|
Cardiac Resynchronization Therapy
|
|
Concept
|
Cardiac Resynchronization Therapy Devices
|
|
Concept
|
Adrenergic beta-1 Receptor Antagonists
|
|
Concept
|
Out-of-Hospital Cardiac Arrest
|
|
Concept
|
Pandemics
|
|
Concept
|
Geographic Mapping
|
|
Concept
|
Tertiary Care Centers
|
|
Concept
|
Forests
|
|
Academic Article
|
Ventricular Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy (Analysis Spanning 60 Years Of Practice): AJC Expert Panel.
|
|
Academic Article
|
Significance and Frequency of Incidental Fortuitous Clinical Identifications of Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction.
|
|
Academic Article
|
The Role of Cardiac MRI in the Diagnosis and Risk Stratification of Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
[Myocardial hypoperfusion due to microvascular dysfunction in hypertrophic cardiomyopathy: role of positron emission tomography].
|
|
Academic Article
|
Syncope and risk of sudden death in hypertrophic cardiomyopathy.
|
|
Academic Article
|
There is No Reason to Adopt ECG s and Abandon American Heart Association/American College of Cardiology History and Physical Screening for Detection of Cardiovascular Disease in the Young.
|
|
Academic Article
|
Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy.
|
|
Academic Article
|
Ventricular Tachyarrhythmias in Patients With Hypertrophic Cardiomyopathy and Defibrillators: Triggers, Treatment, and Implications.
|
|
Academic Article
|
Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
|
|
Academic Article
|
Hypertrophic Cardiomyopathy in Children, Adolescents, and Young Adults Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.
|
|
Academic Article
|
What is the best approach for the assessment of left atrial size? Comparison of various unidimensional and two-dimensional parameters with three-dimensional echocardiographically determined left atrial volume.
|
|
Academic Article
|
Contrast-enhanced CMR in HCM: what lies behind the bright light of LGE and why it now matters.
|
|
Academic Article
|
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes: A Scientific Statement From the American Heart Association and American College of Cardiology.
|
|
Academic Article
|
Current practices in the identification of critical habitat for threatened species.
|
|
Academic Article
|
Images in cardiovascular medicine. Overlapping phenotypes: left ventricular noncompaction and hypertrophic cardiomyopathy.
|
|
Academic Article
|
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 1: Classification of Sports: Dynamic, Static, and Impact: A Scientific Statement From the American Heart Association and American College of Cardiology.
|
|
Academic Article
|
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology.
|
|
Academic Article
|
Surviving malignant hypertrophic cardiomyopathy with all major complications in a single patient.
|
|
Academic Article
|
Risk stratification in hypertrophic cardiomyopathy: is two-dimensional echocardiographic strain ready for prime time?
|
|
Academic Article
|
Left?ventricular apical aneurysm in hypertrophic cardiomyopathy as a risk factor for sudden death at any age.
|
|
Academic Article
|
A novel patient-patient network medicine approach to refine hypertrophic cardiomyopathy subgrouping: implications for risk stratification.
|
|
Academic Article
|
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
|
|
Academic Article
|
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
|
|
Academic Article
|
Effect of Left Ventricular Outflow Tract Obstruction on Left Atrial Mechanics in Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Prevalence and clinical profile of myocardial crypts in hypertrophic cardiomyopathy.
|
|
Academic Article
|
After 60 Years Hypertrophic Cardiomyopathy is Finally Recognized as a Contemporary Treatable Disease With Low Mortality and Morbidity, But is This Paradigm Under-Recognized in the Literature?
|
|
Academic Article
|
Is Hypertrophic Cardiomyopathy Always a Familial and Inherited Disease?
|
|
Academic Article
|
Efficacy of Combined Cox-Maze IV and Ventricular Septal Myectomy for Treatment of Atrial Fibrillation in Patients With Obstructive Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Anatomic validation of late gadolinium enhancement as evidence of myocardial scarring in LAMP2 cardiomyopathy.
|
|
Academic Article
|
Do Implantable Cardioverter-Defibrillators Really Belong on the Athlete Field?
|
|
Academic Article
|
Comparison of circadian rhythm patterns in Tako-tsubo cardiomyopathy versus ST-segment elevation myocardial infarction.
|
|
Academic Article
|
Novel Approach Targeting the Complex Pathophysiology of Hypertrophic Cardiomyopathy: The Impact of Late Sodium Current Inhibition on Exercise Capacity in Subjects with Symptomatic Hypertrophic Cardiomyopathy (LIBERTY-HCM) Trial.
|
|
Academic Article
|
Research priorities in hypertrophic cardiomyopathy: report of a Working Group of the National Heart, Lung, and Blood Institute.
|
|
Academic Article
|
Response to Letter Regarding Article, "Clinical Impact of Contemporary Cardiovascular Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy".
|
|
Academic Article
|
Coronary embolization in hypertrophic cardiomyopathy with left ventricular apical aneurysm.
|
|
Academic Article
|
Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Reply: The LVAD in the Management of Advanced Heart?Failure Due to Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Hypertrophic cardiomyopathy - Authors' reply.
|
|
Academic Article
|
Evidence That Subcutaneous Implantable Cardioverter-Defibrillators Are Effective and Reliable in Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Increased Long-Term Survival After?Myectomy: Is the Pendulum Swinging Again in This 30-Year Debate?
|
|
Academic Article
|
Timing and significance of exercise-induced left ventricular outflow tract pressure gradients in hypertrophic cardiomyopathy.
|
|
Academic Article
|
Significance of sarcomere gene mutations analysis in the end-stage phase of hypertrophic cardiomyopathy.
|
|
Academic Article
|
Hypertrophic cardiomyopathy: quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR imaging.
|
|
Academic Article
|
Reply: What Is the True Prevalence of Hypertrophic Cardiomyopathy?
|
|
Academic Article
|
Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators.
|
|
Academic Article
|
Sailing Away From the Sarcomere: The Mitral Valve in Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Precision Medicine for All?: What About Hypertrophic Cardiomyopathy?
|
|
Academic Article
|
Association Between Race and Clinical Profile of Patients Referred for Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Global Burden of Hypertrophic?Cardiomyopathy.
|
|
Academic Article
|
Lack of Phenotypic Differences by Cardiovascular Magnetic Resonance Imaging in MYH7 (?-Myosin Heavy Chain)- Versus MYBPC3 (Myosin-Binding Protein C)-Related Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
The 25-year genetic era in hypertrophic cardiomyopathy: revisited.
|
|
Academic Article
|
My approach to clinical management of hypertrophic cardiomyopathy.
|
|
Academic Article
|
Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
|
|
Academic Article
|
Response by Rowin et al to Letter Regarding Article, "Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy".
|
|
Academic Article
|
Commentary: Reoperative apical myectomy, a long run for a short slide, or a clear benefit yet to be determined.
|
|
Academic Article
|
Cardiac biomarkers and effects of aficamten in obstructive hypertrophic cardiomyopathy: the SEQUOIA-HCM trial.
|
|
Academic Article
|
CMR with late gadolinium enhancement in genotype positive-phenotype negative hypertrophic cardiomyopathy.
|
|
Academic Article
|
Progression of Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Cardiac Magnetic Resonance Study.
|
|
Academic Article
|
Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.
|
|
Academic Article
|
Spectrum and significance of electrocardiographic patterns, troponin levels, and thrombolysis in myocardial infarction frame count in patients with stress (tako-tsubo) cardiomyopathy and comparison to those in patients with ST-elevation anterior wall myocardial infarction.
|
|
Academic Article
|
Paradigm of Sudden Death Prevention in Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Hypertrophic Cardiomyopathy: New Concepts and Therapies.
|
|
Academic Article
|
Three-dimensional speckle-tracking echocardiography: methodological aspects and clinical potential.
|
|
Academic Article
|
Medical and Legal Determinants of Sports Eligibility for Young Competitive Athletes With Cardiovascular Disease.
|
|
Academic Article
|
Editorial commentary: Hold your horses (and mice, rats, and cats): How relevant really are animal models of hypertrophic cardiomyopathy?
|
|
Academic Article
|
Contemporary Natural History and Management of Nonobstructive Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
How to Image Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Reply: Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm.
|
|
Academic Article
|
Hypertrophic cardiomyopathy.
|
|
Academic Article
|
Relation of Doppler Tissue Imaging Parameters With Heart Failure Progression in Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Relation of pulse pressure to blood pressure response to exercise in patients with hypertrophic cardiomyopathy.
|
|
Academic Article
|
Jeff Zucker Says Hypertrophic Cardiomyopathy is a Curable Disease: A Patient's Perspective.
|
|
Academic Article
|
Exploring New and Old Therapies for Obstructive Hypertrophic Cardiomyopathy: Mavacamten in Perspective.
|
|
Academic Article
|
Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.
|
|
Academic Article
|
Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.
|
|
Academic Article
|
Ventricular tachycardia/fibrillation early after defibrillator implantation in patients with hypertrophic cardiomyopathy is explained by a high-risk subgroup of patients.
|
|
Academic Article
|
Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
The role of cardiovascular magnetic resonance in sudden death risk stratification in hypertrophic cardiomyopathy.
|
|
Academic Article
|
Arrhythmias in cardiomyopathies. Preface.
|
|
Academic Article
|
Clinical Characteristics and Healthcare Resource Utilization among Patients with Obstructive Hypertrophic Cardiomyopathy Treated in a Range of Settings in the United States.
|
|
Academic Article
|
Hypertrophic Cardiomyopathy and Sudden Death Initially Identified at Autopsy.
|
|
Academic Article
|
Commotio cordis?once again: Unusual occurrence in a noncontact sport.
|
|
Academic Article
|
Clinical Course and Significance of Hypertrophic Cardiomyopathy Without Left Ventricular Hypertrophy.
|
|
Academic Article
|
Right ventricular involvement in hypertrophic cardiomyopathy.
|
|
Academic Article
|
Interaction of Adverse Disease Related Pathways in Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Formin homology 2 domain containing 3 variants associated with hypertrophic cardiomyopathy.
|
|
Academic Article
|
The Guidant Affair revisited?but this time with good news.
|
|
Academic Article
|
Winter Is Coming: The Slippery Slope of Defining Disease and the?Implications?for?Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Occurrence and Natural History of Clinically Silent Episodes of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Cats Have Nine Lives but This Hypertrophic Cardiomyopathy Patient Has Had Ten (So Far).
|
|
Academic Article
|
Reply: Obstructive sleep apnea and hypertrophic cardiomyopathy: obiter dictum or more?
|
|
Academic Article
|
Coexistence of acute takotsubo syndrome and acute coronary syndrome.
|
|
Academic Article
|
Nonobstructive Hypertrophic Cardiomyopathy: Overlooked But Not Forgotten.
|
|
Academic Article
|
Reply: Atrial Fibrillation in Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Distinct Subgroups in Hypertrophic Cardiomyopathy in the NHLBI HCM Registry.
|
|
Academic Article
|
Summary of Presentations and Discussions of Hypertrophic Cardiomyopathy at the 2018 Boston International Summit VI Including Consensus, Controversies, and Unmet Needs.
|
|
Academic Article
|
The ESC Risk Score Is Less Reliable than ACC/AHA Risk Factors in Hypertrophic Cardiomyopathy: When Sensitivity Trumps Specificity.
|
|
Academic Article
|
Clinical Significance of Postoperative Atrial Fibrillation in Hypertrophic Cardiomyopathy Patients Undergoing Septal Myectomy.
|
|
Academic Article
|
Three-dimensional Deep Convolutional Neural Networks for Automated Myocardial Scar Quantification in Hypertrophic Cardiomyopathy: A Multicenter Multivendor Study.
|
|
Academic Article
|
Is Regression of Left Ventricular Hypertrophy Really a Good Thing for Patients With Hypertrophic Cardiomyopathy?: The Emerging Mavacamten Story.
|
|
Academic Article
|
Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes.
|
|
Academic Article
|
Sixty-Year Evolution of Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy with Insights From the Historic NIH Surgical Experience to Present.
|
|
Academic Article
|
Development of the Implantable Cardioverter-Defibrillator: JACC Historical Breakthroughs in Perspective.
|
|
Academic Article
|
Adrenergic receptor polymorphisms in patients with stress (tako-tsubo) cardiomyopathy.
|
|
Academic Article
|
Characteristics of Patients With Obstructive Hypertrophic Cardiomyopathy in Real-World Community-Based Cardiovascular Practices.
|
|
Academic Article
|
Why not just call it tako-tsubo cardiomyopathy: a discussion of nomenclature.
|
|
Academic Article
|
Risk Stratification in Hypertrophic Cardiomyopathy: Highly Effective, But Could It Be Better?
|
|
Academic Article
|
Future Role of New Negative Inotropic Agents in the Era of Established Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: Endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomography.
|
|
Academic Article
|
Pharmacological treatment options for hypertrophic cardiomyopathy: high time for evidence.
|
|
Academic Article
|
Achieving Extended Longevity and Quality of Life for Senior Patients With Hypertrophic Cardiomyopathy: What Is Possible.
|
|
Academic Article
|
Cardiovascular imaging in contemporary cardiology: relative roles of echocardiography, cardiac magnetic resonance and cardiac computed tomography.
|
|
Academic Article
|
Left atrial remodeling in hypertrophic cardiomyopathy and susceptibility markers for atrial fibrillation identified by cardiovascular magnetic resonance.
|
|
Academic Article
|
Feline Hypertrophic Cardiomyopathy: A Spontaneous Large Animal Model of Human HCM.
|
|
Academic Article
|
Radiomics and deep learning for myocardial scar screening in hypertrophic cardiomyopathy.
|
|
Academic Article
|
2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
|
|
Academic Article
|
Identification of Fabry Disease in a Tertiary Referral Cohort of Patients with Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Myocardial Strain in Hypertrophic?Cardiomyopathy: A Force Worth Pursuing?
|
|
Academic Article
|
Hypertrophic Cardiomyopathy in?Adulthood Associated With Low?Cardiovascular Mortality With Contemporary Management Strategies.
|
|
Academic Article
|
LGE Means Better Selection of HCM?Patients for Primary Prevention Implantable Defibrillators.
|
|
Academic Article
|
The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy.
|
|
Academic Article
|
Results of surgical septal myectomy for obstructive hypertrophic cardiomyopathy: the Tufts experience.
|
|
Academic Article
|
Double or compound sarcomere mutations in hypertrophic cardiomyopathy: a potential link to sudden death in the absence of conventional risk factors.
|
|
Academic Article
|
Local conditions and policy design determine whether ecological compensation can achieve No Net Loss goals.
|
|
Academic Article
|
Role of Exercise Testing in Hypertrophic?Cardiomyopathy.
|
|
Academic Article
|
Letter by Maron et al Regarding Article, "Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe)".
|
|
Academic Article
|
Utility of cardiovascular magnetic resonance in the diagnosis of Anderson-Fabry disease.
|
|
Academic Article
|
Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy.
|
|
Academic Article
|
Independent Assessment of the European Society of Cardiology Sudden Death Risk Model for Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Nonobstructive Hypertrophic Cardiomyopathy Out of the Shadows: Known from the Beginning but Largely Ignored ? Until Now.
|
|
Academic Article
|
Outcomes in Patients With Hypertrophic Cardiomyopathy and Left Ventricular Systolic Dysfunction.
|
|
Academic Article
|
The dilemma of left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy: do patients with gradients really deserve prophylactic defibrillators?
|
|
Academic Article
|
Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine.
|
|
Academic Article
|
A Discussion of Contemporary Nomenclature, Diagnosis, Imaging, and Management of Patients With Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Temporal and Global Trends of the Incidence of Sudden Cardiac Death in Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Author Correction: Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes.
|
|
Academic Article
|
PRKAG2 Glycogen Storage Disease Cardiomyopathy: Out of the Darkness and Into the Light.
|
|
Academic Article
|
Identification of Transthyretin Cardiac Amyloidosis Among Patients Previously Diagnosed With Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
How should hypertrophic cardiomyopathy be classified?: What's in a name? Dilemmas in nomenclature characterizing hypertrophic cardiomyopathy and left ventricular hypertrophy.
|
|
Academic Article
|
Peripheral vascular endothelial function in patients with hypertrophic cardiomyopathy.
|
|
Academic Article
|
A Case of Multiple Ventricular Gradients.
|
|
Academic Article
|
Hypertrophic Cardiomyopathy: Is a 'Cure' Coming . . . Or Is It Already Here?
|
|
Academic Article
|
Phase 2 Study of Aficamten in Patients?With Obstructive Hypertrophic?Cardiomyopathy.
|
|
Academic Article
|
Aficamten for Drug-Refractory Severe Obstructive Hypertrophic Cardiomyopathy in Patients Receiving Disopyramide: REDWOOD-HCM Cohort 3.
|
|
Academic Article
|
Underappreciated occurrence of discrete subaortic membranes producing left ventricular outflow obstruction in hypertrophic cardiomyopathy.
|
|
Academic Article
|
Survival Following Alcohol Septal Ablation or Septal Myectomy for Patients?With Obstructive Hypertrophic?Cardiomyopathy.
|
|
Academic Article
|
QRS Fragmentation as a Risk Marker for Sudden Death in Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Out With the Old and in With the New: Not So Fast in Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Significance and relation between magnitude of left ventricular hypertrophy and heart failure symptoms in hypertrophic cardiomyopathy.
|
|
Academic Article
|
New perspectives on the prevalence of hypertrophic cardiomyopathy.
|
|
Academic Article
|
Prognostic role of left ventricular apical aneurysm in hypertrophic cardiomyopathy: A systematic review and meta-analysis.
|
|
Academic Article
|
Plasma Proteomic Profiling in Hypertrophic Cardiomyopathy Patients before and after Surgical Myectomy Reveals Post-Procedural Reduction in Systemic Inflammation.
|
|
Academic Article
|
Case for Earlier Surgical Myectomy in Patients With Obstructive Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Changing Demographics in Hypertrophic Cardiomyopathy and Implications for Management: Clinical Research.
|
|
Academic Article
|
Significance of false negative electrocardiograms in preparticipation screening of athletes for hypertrophic cardiomyopathy.
|
|
Academic Article
|
Successful therapeutic hypothermia in patients with hypertrophic cardiomyopathy.
|
|
Academic Article
|
Cardiovascular magnetic resonance for screening in hypertrophic cardiomyopathy: the new family plan.
|
|
Academic Article
|
Left Ventricular Apex Involvement in Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Hypertrophic cardiomyopathy with right ventricular outflow tract and left ventricular intracavitary obstruction.
|
|
Academic Article
|
Usefulness of Global Longitudinal Strain to Predict Heart Failure Progression in Patients With Nonobstructive Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Acute and reversible cardiomyopathy provoked by stress in women from the United States.
|
|
Academic Article
|
Cardiovascular magnetic resonance imaging for bicuspid aortic valve syndrome: the time is now.
|
|
Academic Article
|
Spectrum and clinical significance of systolic function and myocardial fibrosis assessed by cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
|
|
Academic Article
|
Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy.
|
|
Academic Article
|
Papillary muscle insertion directly into the anterior mitral leaflet in hypertrophic cardiomyopathy, its identification and cause of outflow obstruction by cardiac magnetic resonance imaging, and its surgical management.
|
|
Academic Article
|
Author Correction: Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypes.
|
|
Academic Article
|
Hypertrophic Cardiomyopathy in "Real-World" Community Cardiology Practice.
|
|
Academic Article
|
How Hypertrophic Cardiomyopathy Became a Contemporary Treatable Genetic Disease With Low Mortality: Shaped by 50 Years of Clinical Research and Practice.
|
|
Academic Article
|
Corrigendum to 'Syncope in hypertrophic cardiomyopathy (part II): An expert consensus statement on the diagnosis and management' [International Journal of Cardiology, 2023, 41:180-186].
|
|
Academic Article
|
Evolving Contemporary Management of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Refining Endpoint Measures in Clinical Trials for Hypertrophic Cardiomyopathy: The Emerging Role of Patient-Reported Outcomes.
|
|
Academic Article
|
Benefit of Cardiac Resynchronization Therapy in End-Stage Nonobstructive Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Exercise Capacity in Patients With?Obstructive Hypertrophic?Cardiomyopathy: SEQUOIA-HCM Baseline Characteristics and Study Design.
|
|
Academic Article
|
Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance.
|
|
Academic Article
|
Distinctive Hypertrophic Cardiomyopathy Anatomy and Obstructive Physiology in Patients Admitted With Takotsubo Syndrome.
|
|
Academic Article
|
Significance of Late Gadolinium Enhancement at Right Ventricular Attachment to Ventricular Septum in Patients With Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
The case for myocardial ischemia in hypertrophic cardiomyopathy.
|
|
Academic Article
|
Significance of left ventricular apical-basal muscle bundle identified by cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
|
|
Academic Article
|
Development and Validation of a Clinical Predictive Model for Identifying Hypertrophic Cardiomyopathy Patients at Risk for Atrial Fibrillation: The HCM-AF Score.
|
|
Academic Article
|
Reply: Nonobstructive Hypertrophic Cardiomyopathy: Low Mortality but Not Always Benign.
|
|
Academic Article
|
Identification of high-risk imaging features in hypertrophic cardiomyopathy using electrocardiography: A deep-learning approach.
|
|
Academic Article
|
Predictors of Major Atrial Fibrillation Endpoints in the National Heart, Lung, and Blood Institute HCMR.
|
|
Academic Article
|
Left ventricular twist mechanics in hypertrophic cardiomyopathy assessed by three-dimensional speckle tracking echocardiography.
|
|
Academic Article
|
Adult Monozygotic Twins With Hypertrophic Cardiomyopathy and Identical Disease Expression and Clinical Course.
|
|
Academic Article
|
Differing strategies for sudden death prevention in hypertrophic cardiomyopathy.
|
|
Academic Article
|
Costs and Healthcare Resource Utilization for Obstructive Hypertrophic Cardiomyopathy With Septal Reduction Therapy.
|
|
Academic Article
|
Syncope in hypertrophic cardiomyopathy (part II): An expert consensus statement on the diagnosis and management.
|
|
Academic Article
|
Moving Beyond the Sarcomere to Explain?Heterogeneity in Hypertrophic?Cardiomyopathy: JACC Review Topic of the Week.
|
|
Academic Article
|
Hypertrophic cardiomyopathy in childhood: the gradient is not the disease. Excessive use of experimental invasive interventions.
|
|
Academic Article
|
Risk stratification and outcome of patients with hypertrophic cardiomyopathy >=60 years of age.
|
|
Academic Article
|
Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.
|
|
Academic Article
|
A paradigm shift in our understanding of the development of the hypertrophic cardiomyopathy phenotype?: not so fast!
|
|
Academic Article
|
Prediction and Prevention of Sudden Death in Young Patients (<20 years) With Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Clinical Profile of Nonresponders to Surgical Myectomy with Obstructive Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Intermediate-signal-intensity late gadolinium enhancement predicts ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy.
|
|
Academic Article
|
Back to the future: Predicting sudden death in hypertrophic cardiomyopathy relying on individual risk markers and physician judgment without mathematical scoring.
|
|
Academic Article
|
Chronic Heart Failure Is Infrequently Associated With Renal Dysfunction in Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Low Operative Mortality Achieved With Surgical Septal Myectomy: Role of Dedicated Hypertrophic Cardiomyopathy Centers in the Management of Dynamic Subaortic Obstruction.
|
|
Academic Article
|
Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Structurally Normal Hearts Are Uncommonly Associated With Sudden Deaths in Athletes and Young People.
|
|
Academic Article
|
Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy.
|
|
Academic Article
|
Is It Fair to Screen Only Competitive Athletes for Sudden Death Risk, or Is It Time to Level the Playing Field?
|
|
Academic Article
|
Shared decision-making in HCM.
|
|
Academic Article
|
[The current and emerging role of cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy].
|
|
Academic Article
|
Guideline-Based Referral for Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy Is Associated With Excellent Clinical Outcomes.
|
|
Academic Article
|
Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy.
|
|
Academic Article
|
Clinical Spectrum and Management?of?Heart Failure in?Hypertrophic?Cardiomyopathy.
|
|
Academic Article
|
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes: A Scientific Statement From the American Heart Association and American College of Cardiology.
|
|
Academic Article
|
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 1: Classification of Sports: Dynamic, Static, and Impact: A Scientific Statement From the American Heart Association and American College of Cardiology.
|
|
Academic Article
|
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology.
|
|
Academic Article
|
J Point Elevation in Hypertrophic?Cardiomyopathy: Riding a New Wave in Risk Stratification?
|
|
Academic Article
|
Sports and arrhythmias: a report of the International Workshop Venice Arrhythmias 2009.
|
|
Academic Article
|
Assessment of left ventricular hypertrophy in a trained athlete: differential diagnosis of physiologic athlete's heart from pathologic hypertrophy.
|
|
Academic Article
|
Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy.
|
|
Academic Article
|
How common is hypertrophic cardiomyopathy? really?: Disease prevalence revisited 27?years after CARDIA.
|
|
Academic Article
|
Impact of comorbidities on atrial fibrillation and sudden cardiac death in hypertrophic cardiomyopathy.
|
|
Academic Article
|
Prognostic Implications of Nonsustained Ventricular Tachycardia in High-Risk Patients With Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Importance of newer cardiac magnetic resonance-based risk markers for sudden death prevention in hypertrophic cardiomyopathy: An international multicenter study.
|
|
Academic Article
|
The current and emerging role of cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy.
|
|
Academic Article
|
What Do Patients With Hypertrophic Cardiomyopathy Die from?
|
|
Academic Article
|
Stress cardiomyopathy.
|
|
Academic Article
|
Imaging techniques in the evaluation and management of hypertrophic cardiomyopathy.
|
|
Academic Article
|
Low Risk of Hypertrophic Cardiomyopathy With Contemporary Management Strategies Implemented in Non-Referral Regional Community-Based Practices.
|
|
Academic Article
|
Impact of Sex on Clinical Course and Survival in the Contemporary Treatment Era for Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Is surgical myectomy challenged by emergence of novel drug therapy with mavacamten?
|
|
Academic Article
|
? Blockers for prevention of exercise-induced left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy.
|
|
Academic Article
|
Clinical Spectrum and Management Implications of Left Ventricular Outflow Obstruction With Mild Ventricular Septal Thickness in Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Automated Cardiac MR Scar Quantification in Hypertrophic Cardiomyopathy Using Deep Convolutional Neural Networks.
|
|
Academic Article
|
Impact of papillary and trabecular muscles on quantitative analyses of cardiac function in hypertrophic cardiomyopathy.
|
|
Academic Article
|
Erratum to "Hypertrophic Cardiomyopathy: Is a 'Cure' Coming ? Or Is It Already Here?": American Journal of Medicine, 133 (2020):8:886-888.
|
|
Academic Article
|
Perspectives on the Overall Risks of Living With Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Evolution of risk stratification and sudden death prevention in hypertrophic cardiomyopathy: Twenty years with the implantable cardioverter-defibrillator.
|
|
Academic Article
|
The Hypertrophic Cardiomyopathy Phenotype Viewed Through the Prism?of?Multimodality Imaging: Clinical and Etiologic Implications.
|
|
Academic Article
|
Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation.
|
|
Academic Article
|
Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives.
|
|
Academic Article
|
Occurrence of Clinically Diagnosed Hypertrophic Cardiomyopathy in the United States.
|
|
Academic Article
|
Analysis of risk stratification and prevention of sudden death in pediatric patients with hypertrophic cardiomyopathy: Dilemmas and clarity.
|
|
Academic Article
|
Improved Quantification of Myocardium Scar in Late Gadolinium Enhancement Images: Deep Learning Based Image Fusion Approach.
|
|
Academic Article
|
Adipositas cordis: an uncommon cardiomyopathy identified by cardiovascular magnetic resonance.
|
|
Academic Article
|
Concerns About the HCM Risk-Kids Study.
|
|
Academic Article
|
Global Dissemination and Implementation of Contemporary Management Principles for Hypertrophic Cardiomyopathy and Role of the International HCM Summit.
|
|
Academic Article
|
Reflections on Six Decades of Hypertrophic Cardiomyopathy From Eugene Braunwald.
|
|
Academic Article
|
Reply: To PMID 25759101.
|
|
Academic Article
|
Single Coil Implantable Cardioverter Defibrillator Leads in Patients With Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Will there ever be a randomized trial?
|
|
Academic Article
|
The Remarkable 50 Years of Imaging in?HCM and How?it Has Changed Diagnosis?and Management: From M-Mode Echocardiography to CMR.
|
|
Academic Article
|
Ventricular Septal Myectomy Decreases Long-Term Risk for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Evidence for Left Ventricular Outflow Tract Obstruction With Minimal Septal Hypertrophy: The Case Grows Stronger for a Multimodality Imaging Strategy for Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
What Causes Hypertrophic Cardiomyopathy?
|
|
Academic Article
|
Clinical Profile of Patients With High-Risk Tako-Tsubo Cardiomyopathy.
|
|
Academic Article
|
"Speckled" ventricular septum in hypertrophic cardiomyopathy revisited after 30 years.
|
|
Academic Article
|
Machine Learning for Predicting Heart Failure Progression in Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Reply: To PMID 23245842.
|
|
Academic Article
|
Clinical Impact of Contemporary Cardiovascular Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
The Paradigm of Sudden Death Prevention in Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Advances in the Management of Hypertrophic Cardiomyopathy Leading to Low Disease-Related Mortality in 2023.
|
|
Academic Article
|
Personalized Treatment Strategies Effective in Hypertrophic Cardiomyopathy Do Not Rely on Genomics in 2022: A Different Tale of Precision Medicine.
|
|
Academic Article
|
Management implications of massive left ventricular hypertrophy in hypertrophic cardiomyopathy significantly underestimated by echocardiography but identified by cardiovascular magnetic resonance.
|
|
Academic Article
|
Family History of Sudden Death Should Be a Primary Indication for Implantable Cardioverter Defibrillator in Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Protected areas and the future of insect conservation.
|
|
Academic Article
|
Safety, Side Effects and Relative Efficacy of Medications for Rhythm Control of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Hypertrophic cardiomyopathy with left ventricular apical aneurysm in brothers.
|
|
Academic Article
|
Evidence of Advanced Pulmonary Vascular Remodeling in Obstructive Hypertrophic Cardiomyopathy With Pulmonary Hypertension.
|
|
Academic Article
|
Hypertrophic Cardiomyopathy Registry: The rationale and design of an international, observational study of hypertrophic cardiomyopathy.
|
|
Academic Article
|
Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.
|
|
Academic Article
|
Impact of Effective Management Strategies on Patients With the Most Extreme Phenotypic Expression of Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Survival after cardiac transplantation in patients with hypertrophic cardiomyopathy.
|
|
Academic Article
|
Significance of papillary muscle abnormalities identified by cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
|
|
Academic Article
|
Light-chain amyloidosis with echocardiographic features of hypertrophic cardiomyopathy.
|
|
Academic Article
|
Risks of the Athletic Field Revisited: Report of Unusual Occurrences of Cardiac Arrest and Sudden Death in Professional Soccer Players.
|
|
Academic Article
|
Establishment of Specialized Clinical Cardiovascular Genetics Programs: Recognizing the Need and Meeting Standards: A Scientific Statement From the American Heart Association.
|
|
Academic Article
|
Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance.
|
|
Academic Article
|
Asymptomatic young man with Danon disease.
|
|
Academic Article
|
Percutaneous left atrial appendage closure for stroke prevention in hypertrophic cardiomyopathy patients with atrial fibrillation.
|
|
Academic Article
|
Surgical Approaches to Hypertrophic Obstructive Cardiomyopathy.
|
|
Academic Article
|
Effect of Spironolactone on Myocardial Fibrosis and Other Clinical Variables in Patients with Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
3-Dimensional Strain Analysis of?Hypertrophic Cardiomyopathy: Insights From the NHLBI International HCM Registry.
|
|
Academic Article
|
Cardiovascular Diseases That Have Emerged From the Darkness.
|
|
Academic Article
|
Long-Term Outcome in High-Risk Patients With Hypertrophic Cardiomyopathy After Primary Prevention Defibrillator Implants.
|
|
Academic Article
|
Syndrome of Reversible Cardiogenic Shock and Left Ventricular Ballooning in Obstructive Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Lifetime Clinical Course of Hypertrophic?Cardiomyopathy: Outcome of the Historical Florence Cohort Over 5 Decades.
|
|
Academic Article
|
Impact of Sodium-Glucose Cotransporter 2 Inhibitors on Mortality in Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status.
|
|
Academic Article
|
The Reply.
|
|
Academic Article
|
Hypertrophic Cardiomyopathy With Left?Ventricular Apical Aneurysm: Implications for Risk Stratification and Management.
|
|
Academic Article
|
Interpretable machine learning for automated left ventricular scar quantification in hypertrophic cardiomyopathy patients.
|
|
Academic Article
|
Outcomes Over Follow-up =10 Years After Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
The ever expanding spectrum of phenotypic diversity in hypertrophic cardiomyopathy.
|
|
Academic Article
|
Differentiating left ventricular hypertrophy in athletes from that in patients with hypertrophic cardiomyopathy.
|
|
Academic Article
|
Why we need more septal myectomy surgeons: An emerging recognition.
|
|
Academic Article
|
Velocity vector imaging in the measurement of left ventricular myocardial mechanics on cardiac magnetic resonance imaging: correlations with echocardiographically derived strain values.
|
|
Academic Article
|
Impact of Aficamten on Echocardiographic Cardiac Structure and Function in Symptomatic Obstructive Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Effect of Aficamten on Cardiac Structure?and Function in Obstructive Hypertrophic Cardiomyopathy: SEQUOIA-HCM CMR Substudy.
|
|
Academic Article
|
Effect of Aficamten on Health Status?Outcomes in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM.
|
|
Academic Article
|
Aficamten and Cardiopulmonary Exercise Test Performance: A Substudy of the SEQUOIA-HCM Randomized Clinical Trial.
|
|
Academic Article
|
Echocardiographic profiles in hypertrophic cardiomyopathy: imaging beyond the septum and systolic anterior motion.
|
|
Academic Article
|
Contemporary strategies for risk stratification and prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy.
|
|
Academic Article
|
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
|
|
Academic Article
|
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
|
|
Academic Article
|
Hypertrophic cardiomyopathy with left ventricular apical aneurysm: the newest high-risk phenotype.
|
|
Academic Article
|
Contemporary surgical management of hypertrophic cardiomyopathy, the need for more myectomy surgeons and disease-specific centers, and the Tufts initiative.
|
|
Academic Article
|
Diagnosis and Evaluation of Hypertrophic?Cardiomyopathy: JACC State-of-the-Art Review.
|
|
Academic Article
|
Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review.
|
|
Academic Article
|
Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy.
|
|
Academic Article
|
Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy.
|
|
Academic Article
|
Mechanism of Progressive Heart Failure and Significance of Pulmonary Hypertension in Obstructive Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience.
|
|
Academic Article
|
Myocardial crypts in hypertrophic cardiomyopathy: the new gang in town.
|
|
Academic Article
|
The 20 advances that have defined contemporary hypertrophic cardiomyopathy.
|
|
Academic Article
|
The case for surgery in obstructive hypertrophic cardiomyopathy.
|
|
Academic Article
|
Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment.
|
|
Academic Article
|
Altered intercellular communication and extracellular matrix signaling as a potential disease mechanism in human hypertrophic cardiomyopathy.
|
|
Academic Article
|
Myocardial Scarring and Sudden Cardiac Death in Young Patients With Hypertrophic Cardiomyopathy: A Multicenter Cohort Study.
|
|
Academic Article
|
Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM.
|
|
Academic Article
|
Letter by Maron et al Regarding Article, "Sudden Cardiac Death in National Collegiate Athletic Association Athletes".
|
|
Academic Article
|
Experience With Extended Follow-Up of?Prophylactically Implanted Defibrillators?for High-Risk Patients With?Hypertrophic?Cardiomyopathy.
|
|
Academic Article
|
Standard-of-Care Medication Withdrawal in Patients With Obstructive Hypertrophic Cardiomyopathy Receiving Aficamten in FOREST-HCM.
|
|
Academic Article
|
Protein Biomarkers of Adverse Clinical Features and Events in Sarcomeric Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Endpoint Selection in Randomized Clinical Trials for Hypertrophic Cardiomyopathy.
|
|
Academic Article
|
Cardiovascular outcomes of glucagon-like peptide-1 agonist in patients with obesity and hypertrophic cardiomyopathy.
|
|
Academic Article
|
Safety and Efficacy of Mavacamten and Aficamten in Patients With Hypertrophic Cardiomyopathy.
|